MoneyAM MoneyAM
 Home   Log In   Register   Our Services   My Account   Contact   Help 
 Stockwatch   Level 2   Portfolio   Charts   Research   Share Price   Awards   Indices   Market Scan   Company Zone   Traders' Room 
 Funds   Trades   Terminal   Alerts   Heatmaps   News   Stock Screener   Forward Diary   Forex Prices   Director Deals   Investors' Room 
 CFDs   Shares   SIPPs   ISAs   Forex   ETFs   Videos   Comparison Tables   Spread Betting   Broker Notes   Shares Magazine 
You are NOT currently logged in

 
Filter Criteria  
Epic: Keywords: 
From: Time:  (hh:mm) RNS:  MonAM: 
To: Time:  (hh:mm)
Please Note - Streaming News is only available to subscribers to the Active Level and above
 


EARNINGS UPDATES: Belvoir ups yearly payout; SigmaRoc swings to profit

ALN

The following is a round-up of updates by London-listed companies, issued on Monday not separately reported by Alliance News.

---------

Belvoir Group PLC - Lincolnshire, England-based property franchise and financial services - Posts revenue of £33.7 million for 2022, up 14% from £29.6 million in 2021. Revenue from the financial services division increases by 26% to £18.1 million, from £14.4 million a year earlier. Pretax profit drops slightly to £9.1 million from £9.3 million, as administrative costs rise by 16% to £11.2 million from £9.7 million a year earlier. Declares a final dividend of 5.0 pence per share, up 11% from 4.5p a year earlier. This takes the total dividend for 2022 to 9.0p per share, up 5.9% from 8.5p a year prior. Looking ahead, says remains confident that it will perform well against the market in 2023 and beyond.

----------

SigmaRoc PLC - quarried materials company - Says revenue for 2022 is £538.0 million, up 98% from £272.0 million in 2021. Swings to a pretax profit of £42.7 million from a loss of £2.3 million, as profit from operations surges to £115.9 million from £61.9 million a year earlier. Earnings before interest, tax, depreciation and amortisation amount to £101.7 million, up from £49.3 million in 2021. Earnings per share total 8.0 pence per share, up from 5.4p in 2021. Chief Executive Officer Max Vermorken says the group has delivered performance well ahead of expectations in 2022, and that the start of 2023 has been encouraging.

----------

Plexus Holdings PLC - West Sussex-based engineering services provider - For the six months ended on December 31, sales revenue is £709,000, down from £734,000 a year before. Pretax loss widens to £2.1 million from £1.9 million, as administrative expenses increase to £2.6 million from £2.5 million in 2021. Says the loss comes after absorbing depreciation and amortisation costs of about £800,000. Chief Executive Ben van Bilderbeek says: ‘While the first half of this financial year continued to be challenging with low sales revenue and trading losses, I am encouraged by a number of positive internal and external indicators and developments.’ Looking ahead, Plexus warns of headwinds in Europe and UK, but says that the global wellhead equipment market is now beginning to thrive, which it says can be positive for the firm.

----------

Northamber PLC - London-based distributor of audio-visual and information technology equipment - Posts revenue of £33.6 million for the six months ended on December 31, up 4.1% from £32.3 million a year before. However, pretax loss widens to £250,000 from £116,000, as administrative costs increase to £1.8 million from £1.6 million a year earlier. Declares an interim dividend of 0.3 pence per share. Looking ahead, Northamber says it remains cautiously optimistic that the investments it has made in supporting its partners will ‘continue to drive growth of strategic business units although some of these investments returns have been hampered by the impact of inflationary issues’.

----------

Bioventix PLC - London-based biotechnology company - Says revenue for 2022 increases by 25% to £5.9 million from £4.7 million in 2021. Says sales of physical product have performed well, and revenue from its vitamin D antibody and other core antibodies have all increased as anticipated. Pretax profit climbs by 27% to £4.5 million from £3.6 million, as operating profit grows to £4.5 million from £3.6 million a year earlier. Declares interim dividend of 62 pence per share, up 20% from 52p a year prior. Looking ahead, says it remains optimistic about its troponin revenue and looks forward to reporting further progress in the second half of the year.

---------

Copyright 2023 Alliance News Ltd. All Rights Reserved.